Initiator Pharma A/S
INIT
Rank in Stocks
#27098
Initiator Pharma A/S is a clinical-stage life sciences firm dedicated to... Initiator Pharma A/S is a clinical-stage life sciences firm dedicated to discovering therapeutic solutions for critical unmet medical needs affecting the central and peripheral nervous systems. Its development pipeline features several clinical-phase compounds: IP2018, a monoamine reuptake inhibitor aimed at psychogenic erectile dysfunction; IPED2015, designed to address organic erectile dysfunction; and IPTN2021, an orphan drug candidate for severe neuropathic pain. Additionally, the company holds early-stage assets, including IPNP2015 for chronic pain management and IPDP2015 for depression. Established in 2016, Initiator Pharma A/S maintains its headquarters in Copenhagen, Denmark.
Share Price
$0.24486274
Last synced: 2026-11-09
Market Cap
$16.76M
Change (1 day)
11.10%
Change (1 year)
-18.45%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Initiator Pharma A/S (INIT)
Category
Healthcare
Earnings for Initiator Pharma A/S (INIT)
Earnings in Jun 2026 TTM: $-4.66M
According to Initiator Pharma A/S's latest financial reports, its current earnings (TTM) are $-4.66M. In 2025 the company earned $-2.68M, a decrease compared to its 2024 earnings of $-2.07K. The earnings shown on this page are earnings before interest and taxes, or EBIT.
Earnings history for Initiator Pharma A/S from 2016 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $-4.66M | 73.48% |
| 2025 | $-2.68M | 129,590.40% |
| 2024 | $-2.07K | -49.54% |
| 2023 | $-4.10K | -35.42% |
| 2022 | $-6.35K | 71.33% |
| 2021 | $-3.71K | 120.57% |
| 2020 | $-1.68K | 12.28% |
| 2019 | $-1.50K | -23.26% |
| 2018 | $-1.95K | 16.83% |
| 2017 | $-1.67K | 779.37% |
| 2016 | $-189.89 | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $4.76B | -102,299.64% |
US
|
|
| $-2.73B | 58,499.18% |
US
|
|
| $-4.02B | 86,138.85% |
AU
|
|
| $2.83B | -60,778.23% |
BE
|
|
| $1.50B | -32,243.49% |
NL
|
Questions about Initiator Pharma A/S's net income
What is Initiator Pharma A/S's net income?
Initiator Pharma A/S's net income over the last twelve months is $-4.66M, as of Jun 2026.
What was Initiator Pharma A/S's net income in 2025?
In 2025, Initiator Pharma A/S's net income was $-2.68M, compared with $-2.07K in 2024.
How has Initiator Pharma A/S's net income changed since 2020?
From 2020 to 2025, Initiator Pharma A/S's net income was highest in 2020 ($-1.68K) and lowest in 2025 ($-2.68M).
How does Initiator Pharma A/S's net income compare with similar companies?
Initiator Pharma A/S's net income ($-4.66M) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $4.76B.